Upon activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), berberine enhances insulin sensitivity, reduces hepatic glucose output, and has been shown in animal models to increase GLP-1 secretion, although this mechanism has not yet been confirmed in large human trials
"The website was easy to navigate, checkout was simple, and my order shipped quickly
Maintenance support following prescription GLP-1 therapy
All prescriptions are written at the sole discretion of the licensed provider
On social media, most of the microdosing chatter is about small amounts of weight loss, perceived (but not proven!) longevity benefits, and treating many forms of inflammation
Physicians must consider individual risk for these side effects prior to initiating treatment